These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 34368156)

  • 1. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
    Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
    Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
    Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
    Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
    Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
    IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
    Schweer D; McAtee A; Neupane K; Richards C; Ueland F; Kolesar J
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
    Szulc-Kielbik I; Kielbik M
    Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
    Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
    Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets.
    Ren J; Xu B; Ren J; Liu Z; Cai L; Zhang X; Wang W; Li S; Jin L; Ding L
    Brain Sci; 2023 Aug; 13(9):. PubMed ID: 37759870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
    Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
    Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Ge Z; Ding S
    Front Oncol; 2020; 10():590941. PubMed ID: 33224886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting lipid metabolism of macrophages: A new strategy for tumor therapy.
    Shao N; Qiu H; Liu J; Xiao D; Zhao J; Chen C; Wan J; Guo M; Liang G; Zhao X; Xu L
    J Adv Res; 2024 Feb; ():. PubMed ID: 38373649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages for cancer treatment.
    Li M; He L; Zhu J; Zhang P; Liang S
    Cell Biosci; 2022 Jun; 12(1):85. PubMed ID: 35672862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
    Zhu C; Kros JM; Cheng C; Mustafa D
    Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress.
    Shen X; Zhou S; Yang Y; Hong T; Xiang Z; Zhao J; Zhu C; Zeng L; Zhang L
    Front Oncol; 2022; 12():1034842. PubMed ID: 36419877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.